The ang-(1-7)/mas-1 axis attenuates the expression and signalling of TGF-β1 induced by angii in mouse skeletal muscle

Clinical Science

Volumn 127, Issue 4, 2014, Pages 251-264

  Morales, María Gabriela ^a   Ábrigo, Johanna ^a   Meneses, Carla ^a   Simon, Felipe ^a,b   Cisternas, Franco ^a   Rivera, Juan Carlos ^a   Vazquez, Yaneisi ^a   Cabello Verrugio, Claudio ^a  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b Pontificia Universidad Católica de Chile   (Chile)

Author keywords

Angiotensin II; Angiotensin (1 7); Mas; Renin angiotensin system (RAS); Skeletal muscle; Transforming growth factor 1 (TGF 1)

Indexed keywords

ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; APOCYNIN; CATALASE; COLLAGEN; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; MAS 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SHORT HAIRPIN RNA; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84899835280     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130585     Document Type: Article

References (70)

1. Ferreira, A. J., Bader, M. and Santos, R. A. (2012) Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review. Expert Opin. Ther. Pat. 22, 567-574 CrossRef PubMed
2. Fyhrquist, F. and Saijonmaa, O. (2008) Renin-angiotensin system revisited. J. Intern. Med. 264, 224-236 CrossRef PubMed
3. Iwai, M. and Horiuchi, M. (2009) Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens. Res. 32, 533-536 CrossRef PubMed
4. Lubel, J. S., Herath, C. B., Burrell, L. M. and Angus, P. W. (2008) Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J. Gastroenterol. Hepatol. 23, 1327-1338 CrossRef PubMed
5. Mezzano, S. A., Ruiz-Ortega, M. and Egido, J. (2001) Angiotensin II and renal fibrosis. Hypertension 38, 635-638 CrossRef PubMed
6. Basile, J. and Toth, P. P. (2009) Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med. J. 102, S1-S12 CrossRef PubMed
7. Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S. and Sowers, J. R. (2007) Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am. J. Physiol. Heart Circ. Physiol. 293, H2009-H2023 CrossRef PubMed
8. Scheen, A. J. (2004) Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs 64, 2537-2565 CrossRef PubMed
9. Tallant, E. A., Ferrario, C. M. and Gallagher, P. E. (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am. J. Physiol. Heart Circ. Physiol. 289, H1560-H1566 CrossRef PubMed
10. Iwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X. and Greenberg, B. H. (2005) Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am. J. Physiol. Heart Circ. Physiol. 289, H2356-H2363 CrossRef PubMed
11. Marangoni, R. A., Carmona, A. K., Passaglia, R. C., Nigro, D., Fortes, Z. B. and de Carvalho, M. H. (2006) Role of the kallikrein-kinin system in Ang-(1-7)-induced vasodilation in mesenteric arterioles of Wistar rats studied in vivo-in situ. Peptides 27, 1770-1775 CrossRef PubMed
12. Ferrario, C. M., Trask, A. J. and Jessup, J. A. (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am. J. Physiol. Heart Circ. Physiol. 289, H2281-H2290 CrossRef PubMed
13. Benter, I. F., Ferrario, C. M., Morris, M. and Diz, D. I. (1995) Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am. J. Physiol. 269, H313-H319 PubMed
14. Grobe, J. L., Mecca, A. P., Mao, H. and Katovich, M. J. (2006) Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am. J. Physiol. Heart Circ. Physiol. 290, H2417-H2423 CrossRef PubMed
15. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263 CrossRef PubMed
16. Chappell, M. C. (2007) Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension 50, 596-599 CrossRef PubMed
17. Ferreira, A. J., Santos, R. A. and Raizada, M. K. (2012) Angiotensin-(1-7)/angiotensin-converting enzyme 2/mas receptor axis and related mechanisms. Int. J. Hypertens. 2012, 690785 PubMed
18. Cabello-Verrugio, C., Cordova, G. and Salas, J. D. (2012) Angiotensin II: role in skeletal muscle atrophy. Curr. Protein Pept. Sci. 13, 560-569 CrossRef PubMed
19. Cabello-Verrugio, C., Morales, M. G., Cabrera, D., Vio, C. P. and Brandan, E. (2012) Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles. J. Cell. Mol. Med. 16, 752-764 CrossRef PubMed
20. Painemal, P., Acuna, M. J., Riquelme, C., Brandan, E. and Cabello-Verrugio, C. (2013) Transforming growth factor type β1 increases the expression of angiotensin II receptor type 2 by a SMAD-and p38 MAPK-dependent mechanism in skeletal muscle. Biofactors 39, 467-475 CrossRef PubMed
21. Reneland, R., Haenni, A., Andersson, P. E., Andren, B. and Lithell, H. (1999) Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men. Blood Press. 8, 16-22 CrossRef PubMed
22. Reneland, R. and Lithell, H. (1994) Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand. J. Clin. Lab. Invest. 54, 105-111 CrossRef PubMed
23. Munoz, M. C., Giani, J. F., Burghi, V., Mayer, M. A., Carranza, A., Taira, C. A. and Dominici, F. P. (2012) The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7). Regul. Pept. 177, 1-11 CrossRef PubMed
24. Munoz, M. C., Giani, J. F. and Dominici, F. P. (2010) Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul. Pept. 161, 1-7 CrossRef PubMed
25. Acuna, M. J., Pessina, P., Olguin, H., Cabrera, D., Vio, C. P., Bader, M., Munoz-Canoves, P., Santos, R. A., Cabello-Verrugio, C. and Brandan, E. (2013) Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling. Hum. Mol. Genet. 23, 1237-1349 CrossRef PubMed
26. Burks, T. N., Andres-Mateos, E., Marx, R., Mejias, R., Van Erp, C., Simmers, J. L., Walston, J. D., Ward, C. W. and Cohn, R. D. (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci. Transl. Med. 3, 82ra37 CrossRef PubMed
27. Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L. et al. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210 CrossRef PubMed
28. Morales, M. G., Vazquez, Y., Acuna, M. J., Rivera, J. C., Simon, F., Salas, J. D., Alvarez Ruf, J., Brandan, E. and Cabello-Verrugio, C. (2012) Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor β1 expression in skeletal muscle cells. Int. J. Biochem. Cell Biol. 44, 1993-2002 CrossRef PubMed
29. Cabello-Verrugio, C. and Brandan, E. (2007) A novel modulatory mechanism of transforming growth factor-β signaling through decorin and LRP-1. J. Biol. Chem. 282, 18842-18850 CrossRef PubMed
30. Droguett, R., Cabello-Verrugio, C., Riquelme, C. and Brandan, E. (2006) Extracellular proteoglycans modify TGF-β bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol. 25, 332-341 CrossRef PubMed
31. Droguett, R., Cabello-Verrugio, C., Santander, C. and Brandan, E. (2010) TGF-β receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation. Exp. Cell Res. 316, 2487-2503 CrossRef PubMed
32. Chen, Y. W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R. and Hoffman, E. P. (2005) Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy. Neurology 65, 826-834 CrossRef PubMed
33. Otis, J. S., Brown, L. A. and Guidot, D. M. (2007) Oxidant-induced atrogin-1 and transforming growth factor-β1 precede alcohol-related myopathy in rats. Muscle Nerve 36, 842-848 CrossRef PubMed
34. Mendias, C. L., Gumucio, J. P., Davis, M. E., Bromley, C. W., Davis, C. S. and Brooks, S. V. (2011) Transforming growth factor-β induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle Nerve 45, 55-59 CrossRef
35. Nunez-Villena, F., Becerra, A., Echeverria, C., Briceno, N., Porras, O., Armisen, R., Varela, D., Montorfano, I., Sarmiento, D. and Simon, F. (2011) Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid. Redox Signal. 15, 2425-2438 CrossRef PubMed
36. Becerra, A., Echeverria, C., Varela, D., Sarmiento, D., Armisen, R., Nunez-Villena, F., Montecinos, M. and Simon, F. (2011) Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death. Cardiovasc. Res. 91, 677-684 CrossRef PubMed
37. Simon, F., Varela, D. and Cabello-Verrugio, C. (2013) Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell. Signal. 25, 1614-1624 CrossRef PubMed
38. Echeverría, C., Montorfano, I., Sarmiento, D., Becerra, A., Nuñez-Villena, F., Figueroa, X., Cabello-Verrugio, C., Elorza, A., Riedel, C. and Simon, F. (2013) Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells. J. Cell. Mol. Med. 17, 800-814 CrossRef PubMed
39. Simon, F. and Fernandez, R. (2009) Early lipopolysaccharideinduced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J. Hypertens. 27, 1202-1216 CrossRef PubMed
40. Simon, F. and Stutzin, A. (2008) Protein kinase C-mediated phosphorylation of p47 phox modulates platelet-derived growth factor-induced H2O2 generation and cell proliferation in human umbilical vein endothelial cells. Endothelium 15, 175-188 CrossRef PubMed
41. Cabello-Verrugio, C., Cordova, G., Vial, C., Zuniga, L. M. and Brandan, E. (2011) Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway. Cell. Signal. 23, 449-457 CrossRef PubMed
42. Thomas, D. A. and Massague, J. (2005) TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8, 369-380 CrossRef PubMed
43. Morales, M. G., Cabrera, D., Cespedes, C., Vio, C. P., Vazquez, Y., Brandan, E. and Cabello-Verrugio, C. (2013) Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2). Cell Tissue Res. 353, 173-187 CrossRef PubMed
44. Cabello-Verrugio, C., Acuna, M. J., Morales, M. G., Becerra, A., Simon, F. and Brandan, E. (2011) Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells. Biochem. Biophys. Res. Commun. 410, 665-670 CrossRef PubMed
45. Reference deleted
46. Cozzoli, A., Nico, B., Sblendorio, V. T., Capogrosso, R. F., Dinardo, M. M., Longo, V., Gagliardi, S., Montagnani, M. and De Luca, A. (2011) Enalapril treatment discloses an early role of angiotensin II in inflammation-and oxidative stress-related muscle damage in dystrophic mdx mice. Pharmacol. Res. 64, 482-492 CrossRef PubMed
47. Katovich, M. J., Grobe, J. L. and Raizada, M. K. (2008) Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Curr. Hypertens. Rep. 10, 227-232 CrossRef PubMed
48. Schindler, C., Bramlage, P., Kirch, W. and Ferrario, C. M. (2007) Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc. Health Risk Manag. 3, 125-137 PubMed
49. Giani, J. F., Munoz, M. C., Pons, R. A., Cao, G., Toblli, J. E., Turyn, D. and Dominici, F. P. (2011) Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 300, F272-F282 CrossRef PubMed
50. Pei, Z., Meng, R., Li, G., Yan, G., Xu, C., Zhuang, Z., Ren, J. and Wu, Z. (2010) Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs. Toxicol. Lett. 199, 173-181 CrossRef PubMed
51. Velkoska, E., Dean, R. G., Griggs, K., Burchill, L. and Burrell, L. M. (2011) Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clin. Sci. 120, 335-345 CrossRef PubMed
52. Zhang, J., Noble, N. A., Border, W. A. and Huang, Y. (2010) Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am. J. Physiol. Renal Physiol. 298, F579-F588 CrossRef PubMed
53. Menon, J., Soto-Pantoja, D. R., Callahan, M. F., Cline, J. M., Ferrario, C. M., Tallant, E. A. and Gallagher, P. E. (2007) Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 67, 2809-2815 CrossRef PubMed
54. Soto-Pantoja, D. R., Menon, J., Gallagher, P. E. and Tallant, E. A. (2009) Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol. Cancer Ther. 8, 1676-1683 CrossRef PubMed
55. Tassone, E. J., Sciacqua, A., Andreozzi, F., Presta, I., Perticone, M., Carnevale, D., Casaburo, M., Hribal, M. L., Sesti, G. and Perticone, F. (2013) Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. Cardiovasc. Res. 99, 129-136 CrossRef PubMed
56. Hayashi, N., Yamamoto, K., Ohishi, M., Tatara, Y., Takeya, Y., Shiota, A., Oguro, R., Iwamoto, Y., Takeda, M. and Rakugi, H. (2010) The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells. Hypertens. Res. 33, 1182-1185 CrossRef PubMed
57. Chen, Q., Yang, Y., Huang, Y., Pan, C., Liu, L. and Qiu, H. (2013) Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury. J. Surg. Res. 185, 740-747 CrossRef PubMed
58. He, J. G., Chen, S. L., Huang, Y. Y., Chen, Y. L., Dong, Y. G. and Ma, H. (2010) The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-β1/Smad2 expression. Heart Vessels 25, 438-443 CrossRef PubMed
59. Zeng, W., Chen, W., Leng, X., He, J. G. and Ma, H. (2009) Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-β/Smad signaling pathway in rabbits. Biochem. Biophys. Res. Commun. 389, 138-144 CrossRef PubMed
60. Reid, M. B., Andrade, F. H., Balke, C. W. and Esser, K. A. (2005) Redox mechanisms of muscle dysfunction in inflammatory disease. Phys. Med. Rehabil. Clin. N. Am. 16, 925-949, ix CrossRef PubMed
61. Kim, J. H., Kwak, H. B., Thompson, L. V. and Lawler, J. M. (2012) Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy. J. Muscle Res. Cell Motil. 34, 1-13 CrossRef PubMed
62. Inoue, N., Kinugawa, S., Suga, T., Yokota, T., Hirabayashi, K., Kuroda, S., Okita, K. and Tsutsui, H. (2012) Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 302, H1202-H1210 CrossRef PubMed
63. Fulle, S., Protasi, F., Di Tano, G., Pietrangelo, T., Beltramin, A., Boncompagni, S., Vecchiet, L. and Fano, G. (2004) The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp. Gerontol. 39, 17-24 CrossRef PubMed
64. Benter, I. F., Yousif, M. H., Dhaunsi, G. S., Kaur, J., Chappell, M. C. and Diz, D. I. (2008) Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am. J. Nephrol. 28, 25-33 CrossRef PubMed
65. Beyer, A. M., Guo, D. F. and Rahmouni, K. (2013) Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity. J. Hypertens. 31, 730-738 CrossRef PubMed
66. Raffai, G., Durand, M. J. and Lombard, J. H. Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am. J. Physiol. Heart Circ. Physiol. 301, H1341-H1352 CrossRef
67. Xu, P., Costa-Goncalves, A. C., Todiras, M., Rabelo, L. A., Sampaio, W. O., Moura, M. M., Santos, S. S., Luft, F. C., Bader, M., Gross, V. et al. (2008) Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension 51, 574-580 CrossRef PubMed
68. McCollum, L. T., Gallagher, P. E. and Tallant, E. A. (2012) Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. Am. J. Physiol. Heart Circ. Physiol. 302, H801-H810 CrossRef PubMed
69. McCollum, L. T., Gallagher, P. E. and Tallant, E. A. (2012) Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts. Peptides 34, 380-388 CrossRef PubMed
70. Gava, E., Samad-Zadeh, A., Zimpelmann, J., Bahramifarid, N., Kitten, G. T., Santos, R. A., Touyz, R. M. and Burns, K. D. (2009) Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells. Nephrol. Dial. Transplant. 24, 1766-1773 CrossRef PubMed